Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02796352
Brief Title: A Phase II Study of High Dose Bolus IL2 in Patients With Inoperable Stage III or Stage IV Melanoma Who Have Failed Prior Anti-PD1 Immunotherapy: Efficacy and Biomarker Study

First Submitted : June 6, 2016
First Submitted that Met QC Criteria : June 6, 2016
First Posted : June 10, 2016 (Estimate)

Results First Submitted : February 19, 2018
Results First Submitted that Met QC Criteria : March 21, 2018
Results First Posted : April 20, 2018

Last Update Submitted that Met QC Criteria : March 21, 2018
Last Update Posted : April 20, 2018